I know this sounds foolish but this should not sell for less than $10 a share after approval. That's about $1.2-1.3B mkt cap. With already approved drugs on the mkt/waiting to be marketed and a pipeline of one drug a year for five years plus you can use these injectors at home for a multitude of drugs with better results/less side effects from deep injection or gastro ingestion I see this company being worth north of $5B in 3 years but unfortunately it won't be around that long. I'm so confident in its long term prospects holding in my IRA that if they sold for $20 I'd be a bit disappointed. Call me a cheerleader.